PZ-51 (Ebselen) in vivo protection against Adriamycin-induced mouse cardiac and hepatic lipid peroxidation and toxicity
Authors:
- 1 August 1992
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 44 (4) , 839-841
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- N-acetylcysteine and glutathione-dependent protective effect of PZ51 (Ebselen) against diquat-induced cytotoxicity in isolated hepatocytesBiochemical Pharmacology, 1987
- A novel biologically active selenoorganic compound—IVBiochemical Pharmacology, 1985
- Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycinBiochemical Pharmacology, 1985
- A novel biologically active seleno-organic compound—IIBiochemical Pharmacology, 1984
- A novel biologically active seleno-organic compound—1Biochemical Pharmacology, 1984
- Stimulation by adriamycin of rat heart and liver microsomal NADPH-dependent lipid peroxidationBiochemical Pharmacology, 1981
- Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen MetabolitesJournal of Clinical Investigation, 1980
- Bioactivation as a Model for Drug Design Bioreductive AlkylationScience, 1977
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycinBiochemical and Biophysical Research Communications, 1977